Barclays Reiterates an 'Overweight' on TransDigm (TDG); Continue To Be Astounded
Tweet
Share
E-mailGet Alerts TDG Hot Sheet
Price: $1,215.34 --0%
Rating Summary:
19 Buy, 15 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 22 | New: 45
Rating Summary:
19 Buy, 15 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 22 | New: 45
Join SI Premium – FREE
Barclays reiterates an 'Overweight' on TransDigm (NYSE: TDG) price target raised from $140 to $150.
Analyst, Carter Copeland, said, "The revelation that YTD underlying adjusted EBITDA margins (including McKechnie closed in Dec 2010) were ~50% in the quarter to us validates the substantial value created by TDG's acquisition model...Even without additional M&A, we can see peak EPS of $11.00+ in FY2015 with adjusted EPS growing in the mid-20% range FY11-FY15 (justifying a high-teens multiple in our view)."
Copeland raises FY12 EPS estimate from $6.10 to $6.57 and FY13 from $7.40 tp $7.95 and names TransDigm as a long-term Top Pick and notes that there has been no signal of a slowdown for this company and it's story.
For an analyst ratings summary and ratings history on TransDigm click here. For more ratings news on TransDigm click here.
Shares of TransDigm closed at $128.51 yesterday.
Analyst, Carter Copeland, said, "The revelation that YTD underlying adjusted EBITDA margins (including McKechnie closed in Dec 2010) were ~50% in the quarter to us validates the substantial value created by TDG's acquisition model...Even without additional M&A, we can see peak EPS of $11.00+ in FY2015 with adjusted EPS growing in the mid-20% range FY11-FY15 (justifying a high-teens multiple in our view)."
Copeland raises FY12 EPS estimate from $6.10 to $6.57 and FY13 from $7.40 tp $7.95 and names TransDigm as a long-term Top Pick and notes that there has been no signal of a slowdown for this company and it's story.
For an analyst ratings summary and ratings history on TransDigm click here. For more ratings news on TransDigm click here.
Shares of TransDigm closed at $128.51 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Downgrades TransDigm (TDG) to Equalweight
- H.C. Wainwright Starts Seaport Therapeutics (SPTX) at Buy
- AbraSilver Resource Corp (ABRA:CN) PT Raised to Cdn$21 at Scotiabank
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
